Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 10,881 | 6,036 | 5,917 | 5,096 | 3,670 |
| Gross Profit | 10,881 | 6,036 | 5,917 | 5,096 | 3,670 |
| Operating Expenses | 25,371 | 16,082 | 19,035 | 14,495 | 12,300 |
| Operating Income | -14,490 | -10,046 | -13,118 | -9,399 | -8,630 |
| Interest Expense | 607 | 670 | 678 | 720 | 743 |
| Other Income | 719 | -37 | -2 | -116 | -34 |
| Pre-tax Income | -14,378 | -10,753 | -13,798 | -10,235 | -9,407 |
| Net Income Continuous | -14,378 | -10,653 | -13,798 | -10,235 | -9,407 |
| Net Income | $-14,378 | $-10,653 | $-13,798 | $-10,235 | $-9,407 |
| EPS Basic Total Ops | -22.70 | -65.40 | -85.60 | -64.10 | -59.20 |
| EPS Basic Continuous Ops | -22.68 | -65.44 | -85.65 | -64.13 | -59.16 |
| EPS Diluted Total Ops | -22.70 | -65.40 | -85.60 | -64.10 | -59.20 |
| EPS Diluted Continuous Ops | -22.68 | -65.44 | -85.65 | -64.13 | -59.16 |
| EBITDA(a) | $-14,154 | $-9,645 | $-12,671 | $-8,952 | $-8,263 |